Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
657 - I'm working on building an app for a pharma client. It's a companion for a drug they market. But I'm concerned that the review section in the App Store will put us at risk of being non-compliant. Do you have any suggestions to help?
-
As the concern is that consumer generated content may contravene the regulations, one option is to deactivate the review section (this may be possible depending on the particular App store in question). Alternatively, you could monitor the reviews and have them corrected or removed if they contravene the regulations. More information on monitoring can be found in the guidance document https://www.paab.ca/resources/Online_Activities.pdf
